1. High SVR rates with SMV+SOF in HCV GT1 and GT4 patients with cirrhosis or advanced fibrosis: A real practice analysis from a large regional database in Tuscany, Italy. (10th February 2016) Authors: Salomoni, E.; Gianni, E.; Gragnani, L.; Oliveri, F.; Brunetto, M.R.; Luchi, S.; Bartolozzi, D.; Forte, P.; Sani, S.; Blanc, P.; Sacco, R.; Zignego, A.L.; De Luca, A.; Tacconi, D.; Aquilini, D.; Menichetti, F.; Catalani, C.; Nencioni, C.; Carrai, P.; Chigiotti, S. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort. Issue 3 (4th March 2019) Authors: Bavaro, D. F.; Di Carlo, D.; Zuccalà, P.; Bai, F.; Incardona, F.; Battisti, A.; Giachè, S.; Salomoni, E.; Gagliardini, R.; Di Giambenedetto, S.; Pecorari, M.; Zazzi, M.; De Luca, A.; Bezenchek, A.; Lo Caputo, S. Journal: Infectious diseases Issue: Volume 51:Issue 3(2019) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗